{
}
UBS AG has maintained a "Neutral" rating for Siemens Healthineers shares, setting a target price of 53 euros. Analyst Kavya Deshpande noted challenges in the diagnostics market in China, which could negatively impact Siemens Healthineers' realignment efforts. The stock recently fell to EUR 53.96, indicating a potential downside of 1.78% from the target price.
UBS AG has maintained a "Neutral" rating for Siemens Healthineers shares, setting a target price of 53 euros. Analyst Kavya Deshpande noted challenges in the Chinese diagnostics market for foreign players, which could hinder Siemens Healthineers' realignment efforts. Shares fell 0.7% to EUR 53.96, indicating a downside potential of 1.78% relative to the target price.
UBS has maintained a 'Neutral' rating for Siemens Healthineers, setting a target price of 53 euros. Analyst Kavya Deshpande highlighted challenges in the Chinese diagnostics market, predicting negative trends for foreign companies, which could hinder Siemens Healthineers' realignment efforts.
UBS AG maintains a "Neutral" rating for Siemens Healthineers with a target price of €53, citing challenges in the Chinese diagnostics market that could hinder the company's realignment efforts. As of the latest trading session, shares fell 0.7% to €53.96, indicating a downside potential of 1.78% from the target price. The company is set to release its Q1 2025 key figures on February 6, 2025.
UBS has maintained a 'Neutral' rating for Siemens Healthineers, setting a target price of 53 euros. Analyst Kavya Deshpande noted that the diagnostics market in China is facing challenges, particularly for foreign companies, which could hinder Siemens Healthineers' realignment efforts.
Kavya Deshpande
People
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
ubs rates siemens healthineers shares neutral amid challenging diagnostics market
15:33 24.01.2025
ubs maintains neutral rating for siemens healthineers with target price of 53 euros
15:18 24.01.2025
ubs maintains neutral rating for siemens healthineers with target price of 53 euros
14:07 24.01.2025
ubs maintains neutral rating for siemens healthineers with target price of 53 euros
13:58 24.01.2025
ubs maintains neutral rating for siemens healthineers with target price of 53 euros
13:54 24.01.2025
Trending
Subcategory
Corporate News
Stock Market Updates
Industry Trends
Finance Mergers & Acquisitions
Industry Mergers & Acquisitions
Retail and Consumer Goods
Financial Scams and Security
Market Analysis and Predictions
Global Financial Events
Global Trade Developments
AI Innovations
Banking Regulations
CEO Changes
Hedge Funds & Private Equity
Supply Chain Management
Startups & Entrepreneurship
Funding Rounds & Investments
Central Bank Actions
Workplace Trends
Energy Sector Developments
Countries:
Companies:
Barclays PLC
NVIDIA Corporation
JPMorgan Chase & Co.
Tesla, Inc.
Morgan Stanley
The Goldman Sachs Group, Inc.
Capital One Financial Corporation
Apple Inc.
Wells Fargo & Company
Bank of America Corporation
Huawei Technologies CO. Ltd.
UBS Group AG
Tesmec S.p.A.
Netflix, Inc.
Deutsche Bank RV Global PP
Citigroup Inc.
The Charles Schwab Corporation
SMIC
HSBC Holdings plc
Google Inc.
Currencies:
United States Dollar
Euro
Indian Rupee
Chinese Yuan
Swiss Franc
British Pound Sterling
United Arab Emirates Dirham
Japanese Yen
Hong Kong Dollar
Canadian Dollar
South Korean Won
Singapore Dollar
Australian Dollar
Offshore Chinese Yuan
Danish Krone
Vietnamese Đồng
Brazilian Real
Colombian Peso
Malaysian Ringgit
Swedish Krona
People: